Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol.

Genoux A, Pons V, Radojkovic C, Roux-Dalvai F, Combes G, Rolland C, Malet N, Monsarrat B, Lopez F, Ruidavets JB, Perret B, Martinez LO.

PLoS One. 2011;6(9):e23949. doi: 10.1371/journal.pone.0023949. Epub 2011 Sep 14.

2.

Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F1-ATPase-mediated HDL endocytosis pathway on hepatocytes.

Cardouat G, Duparc T, Fried S, Perret B, Najib S, Martinez LO.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Sep;1862(9):832-841. doi: 10.1016/j.bbalip.2017.05.005. Epub 2017 May 11.

PMID:
28504211
3.

RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.

Malaval C, Laffargue M, Barbaras R, Rolland C, Peres C, Champagne E, Perret B, Tercé F, Collet X, Martinez LO.

Cell Signal. 2009 Jan;21(1):120-7. doi: 10.1016/j.cellsig.2008.09.016. Epub 2008 Oct 7.

PMID:
18948190
4.

Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study.

Genoux A, Lichtenstein L, Ferrières J, Duparc T, Bongard V, Vervueren PL, Combes G, Taraszkiewicz D, Elbaz M, Galinier M, Nassar B, Ruidavets JB, Perret B, Martinez LO.

BMC Med. 2016 Aug 23;14(1):125. doi: 10.1186/s12916-016-0672-9.

5.

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis.

Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezón E, Champagne E, Pineau T, Georgeaud V, Walker JE, Tercé F, Collet X, Perret B, Barbaras R.

Nature. 2003 Jan 2;421(6918):75-9.

PMID:
12511957
6.

Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study.

Genoux A, Ruidavets JB, Ferrières J, Combes G, Lichtenstein L, Pons V, Laffargue M, Taraszkiewicz D, Carrié D, Elbaz M, Perret B, Martinez LO.

J Lipid Res. 2013 Sep;54(9):2550-8. doi: 10.1194/jlr.P036335. Epub 2013 Jun 21.

7.

The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1.

Giorgio V, Bisetto E, Franca R, Harris DA, Passamonti S, Lippe G.

J Bioenerg Biomembr. 2010 Apr;42(2):117-23. doi: 10.1007/s10863-010-9270-2. Epub 2010 Feb 24.

PMID:
20180002
8.

Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.

Martinez LO, Najib S, Perret B, Cabou C, Lichtenstein L.

Atherosclerosis. 2015 Jan;238(1):89-100. doi: 10.1016/j.atherosclerosis.2014.11.017. Epub 2014 Nov 20. Review.

PMID:
25437896
9.

Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase.

González-Pecchi V, Valdés S, Pons V, Honorato P, Martinez LO, Lamperti L, Aguayo C, Radojkovic C.

Microvasc Res. 2015 Mar;98:9-15. doi: 10.1016/j.mvr.2014.11.003. Epub 2014 Nov 8.

PMID:
25445031
10.

Insight into the bind-lock mechanism of the yeast mitochondrial ATP synthase inhibitory peptide.

Corvest V, Sigalat C, Haraux F.

Biochemistry. 2007 Jul 24;46(29):8680-8. Epub 2007 Jun 27.

PMID:
17595113
11.

The β-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells.

Cavelier C, Ohnsorg PM, Rohrer L, von Eckardstein A.

Arterioscler Thromb Vasc Biol. 2012 Jan;32(1):131-9. doi: 10.1161/ATVBAHA.111.238063. Epub 2011 Oct 6.

PMID:
21979433
12.

The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase.

García JJ, Morales-Ríos E, Cortés-Hernandez P, Rodríguez-Zavala JS.

Biochemistry. 2006 Oct 24;45(42):12695-703.

PMID:
17042487
13.

IF(1) distribution in HepG2 cells in relation to ecto-F(0)F (1)ATPsynthase and calmodulin.

Contessi S, Comelli M, Cmet S, Lippe G, Mavelli I.

J Bioenerg Biomembr. 2007 Aug;39(4):291-300. Epub 2007 Sep 13.

PMID:
17851741
14.

Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes.

Fabre AC, Vantourout P, Champagne E, Tercé F, Rolland C, Perret B, Collet X, Barbaras R, Martinez LO.

Cell Mol Life Sci. 2006 Dec;63(23):2829-37.

15.

Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.

Sánchez-Cenizo L, Formentini L, Aldea M, Ortega AD, García-Huerta P, Sánchez-Aragó M, Cuezva JM.

J Biol Chem. 2010 Aug 13;285(33):25308-13. doi: 10.1074/jbc.M110.146480. Epub 2010 Jun 9.

16.

Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability.

Fujikawa M, Imamura H, Nakamura J, Yoshida M.

J Biol Chem. 2012 May 25;287(22):18781-7. doi: 10.1074/jbc.M112.345793. Epub 2012 Apr 9.

17.

Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.

Vantourout P, Radojkovic C, Lichtenstein L, Pons V, Champagne E, Martinez LO.

World J Gastroenterol. 2010 Dec 21;16(47):5925-35. Review.

18.

Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase.

Venard R, Brèthes D, Giraud MF, Vaillier J, Velours J, Haraux F.

Biochemistry. 2003 Jun 24;42(24):7626-36.

PMID:
12809520
19.

The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.

García-Bermúdez J, Cuezva JM.

Biochim Biophys Acta. 2016 Aug;1857(8):1167-1182. doi: 10.1016/j.bbabio.2016.02.004. Epub 2016 Feb 12.

20.

Docking the mitochondrial inhibitor protein IF1 to a membrane receptor different from the F1-ATPase beta subunit.

Lopez-Mediavilla C, Vigny H, Godinot C.

Eur J Biochem. 1993 Jul 15;215(2):487-96.

Supplemental Content

Support Center